- CA$83.30m
- CA$90.28m
- 19
- 55
- 49
- 36
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | -0.289 | 8.66 | 6.21 | 12.1 | 13.1 |
Operating Profit | 0.289 | -8.66 | -6.21 | -12.1 | -13.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.368 | -8.65 | -6.45 | -11.6 | -12.6 |
Net Income After Taxes | -0.368 | -8.65 | -6.45 | -11.6 | -12.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.368 | -8.42 | -5.83 | -10.5 | -11.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.368 | -8.42 | -5.83 | -10.5 | -11.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.02 | -0.013 | -0.02 | -0.02 |